Final answer:
The issue with combining glargine and lispro insulins in the same syringe is that it can disrupt the long-acting effect of glargine, compromising blood sugar control. Insulin is crucial for decreasing blood glucose after meals to manage diabetes effectively.
Step-by-step explanation:
The main issue with mixing glargine (long-duration) and lispro (rapid-acting) insulin in the same syringe is that it can affect the action profile of these insulins. Glargine, designed to be a long-acting insulin, provides a steady level of insulin, which is critical in managing baseline blood glucose levels. On the other hand, Lispro works quickly to manage blood glucose spikes that occur after a meal. When combined, the action of glargine might be altered, which can lead to suboptimal glycemic control. Therefore, c. Cannot be mixed in the same syringe is the main concern when it comes to these two types of insulin.
Insulin injections play an essential role in managing blood glucose levels. For instance, d. Insulin injections allow transport and storage of glucose to decrease blood glucose levels after consuming a large or high-glucose meal. This assists people with diabetes in maintaining blood glucose levels within targeted ranges.